This Medical Device Player Could Be a Top-Notch Pick in 2020

As the coronavirus pandemic has progressed, healthcare companies involved in developing and manufacturing COVID-19 vaccines and therapeutics have become darlings of the stock market. Abiomed (NASDAQ: ABMD) is the company behind Impella products, the only non-surgical heart pumps approved by the US Food and Drug Administration (FDA). The company set itself apart from the pack by obtaining an Emergency Response (EUA) from the FDA for one of its offerings, the Impella RP, for the treatment of patients with COVID-19-related heart failure or pulmonary embolism (blood clots in the EU) received lungs). This approval could, in part, help offset the financial impact of the decline in electoral procedures amid restrictions on home protection.

You should check here to buy the best price guaranteed products.

Last News

Death Row Inmate Richard Glossip Claims That If Police Had Done A Proper Investigation, ‘I Wouldn’t Have Lost So Much Of My Life’

‘I was terrified’: the vet sterilizing Pablo Escobar’s cocaine hippos

Recap: Arizona volleyball outlasts Colorado 3-1 in Boulder behind Sofia Maldonado Diaz's career night

How the Astros made it to the World Series for the third time in five seasons

These 22 Actors Came Clean About Crushing On Costars They Never Actually Dated, And It's Cute As Hell

Nikola Jokic with an and one vs the San Antonio Spurs